Kangtai Biological’s first-quarter profit surged 11x on strong sales
Newswires MT 2022
|
|
|
|
|
||||
|
||||
Trends in Technical Analysis SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.
Short term | Middle term | Long term | |
Tendencies | Bullish | Neutral | Bearish |
Evolution of the income statement
To sell ![]() To buy |
|
Medium consensus | TO BUY |
Number of analysts | 7 |
Last closing price | 80.50 yuan |
Average target price | CNY129.74 |
Average Spread / Target | 61.2% |
Comments are closed.